RC+ Promal Blister β Innovative Arylcyclohexylamine for Laboratory Research
Product name: RC+ Promal Blister
Active substance: 3-MeO-PCPr (3-Methoxyphencyclopentanamine) promalβ
Form: Blister pack with standardized dosages
Purity: β₯ 98.7% (according to independent laboratory report)
Use: For analytical, neuropharmacological and forensic examination only
𧬠What is Promal (3-MeO-PCPr)?
Promal , also known by its chemical name 3-MeO-PCPr , is a member of the arylcyclohexylamine family , structurally related to 3-MeO-PCP and ketamine . It is distinguished by a propanation rather than a piperidine ring structure, leading to a slightly different receptor binding profile and potentially unique dissociative properties βobserved only in vitro. ΠΡΠΏΠ΅ΡΠ΅ 4mmcΠ±Π΅Π½Π·ΠΎΠΊΠ°ΠΈΠ½ Π½Π° ΠΏΡΠ°Ρ ΠΊΡΠΏΠΈ ΡΠ΅Π½ΡΠ°Π½ΠΈΠ»ibogaβ kopenbuy ibogaine hcl onlineβ
π¬ Product Data & Chemical Specifications
| Characteristic | Information |
|---|---|
| Chemical name | 3-Methoxyphencyclopentanamine |
| Molecular formula | C14H21NO |
| Molecular mass | 219.32 g/mol |
| CAS number | Not officially registered |
| Purity | β₯ 98.7% (HPLC and NMR tested) |
| Form | Blister with pellets/tablets (x pieces) |
| Color/condition | White to cream, crystalline or pressed |
β Use Cases (Research Only)
RC+ Promal Blisters are developed for:
- Binding experiments on NMDA receptors
- SAR (structure-activity relationships) research within the arylcyclohexylamines
- Comparative study with ketamine, PCP and O-PCE analogues
- In vitro study of receptor interactions and metabolism
Not intended for human or animal consumption. Use only in a controlled laboratory setting.
β οΈ Possible Disadvantages & Risks
- Unknown long-term effects : No clinical data
- Low water solubility : May be difficult to handle in some analytical methods
- Legal ambiguity : Potentially banned or regulated in some countries
- Potentially unstable when exposed to light and moisture.
- Strong NMDA activity β not suitable for untested systems
π§ͺ Instructions for Use (Laboratory Scenario)
- Storage advice:
- Store in a cool (2β8Β°C), dry and airtight container.
- Avoid: direct sunlight, open humidity
- Application:
- Open blister with sterile forceps or instrument
- Use weighed sample for LC/MS, NMR or receptor binding assays
- Analysis methods:
- NMR for structural verification
- HPLC for purity control
- GC-MS for identification of degradation products
- In vitro binding assays for receptor activity
β Frequently Asked Questions (FAQ)
Is Promal (3-MeO-PCPr) legal in the Netherlands or Belgium?
This substance is not directly regulated by the Opium Act, but may be subject to similar legislation . Always consult local regulations.
What is the difference between 3-MeO-PCP and 3-MeO-PCPr (Promal)?
The most significant structural change is the replacement of the piperidine group (PCP) with a propyl chain in PCPr. This affects lipophilicity, binding affinity, and metabolic behavior.
How do I know if the blister contents are clean?
Each batch includes an individual lab report with HPLC/NMR results and can be delivered digitally upon request.
Can I use this for microdosing or psychonautic experiment?
Absolutely not. This product is strictly intended for laboratory testing. Human consumption is prohibited, unsafe, and against the law.
π§ Recommended Use Cases
- Research into NMDA antagonism in synthetic analogues
- Comparison with dissociatives such as ketamine and 3-MeO-PCP
- Forensic use for detection methods in toxicology labs
- Development of analytical standards for identification of new RCs
π¦ Product overview
| Feature | Detail |
|---|---|
| Product name | RC+ Promal Blister |
| Active substance | 3-MeO-PCPr (3-Methoxyphencyclopentanamine) |
| Form | Blister with x pieces (pellets/tablets) |
| Purity | β₯ 98.7% |
| Usage | For laboratory use only |
| Storage advice | Cool, dry, dark |
| Legal status | Unregulated, analog sensitive possible |
β οΈ Legal and Ethical Disclaimer
RC+ Promal Blister is intended exclusively for analytical and forensic testing by professionals. Not intended for consumption or use outside of a laboratory setting. Any other use is strictly prohibited.
| 5 Π·Π²Π΅Π·Π΄ΠΈ | 0% | |
| 4 Π·Π²Π΅Π·Π΄ΠΈ | 0% | |
| 3 Π·Π²Π΅Π·Π΄ΠΈ | 0% | |
| 2 Π·Π²Π΅Π·Π΄ΠΈ | 0% | |
| 1 Π·Π²Π΅Π·Π΄Π° | 0% |
Π‘ΡΠΆΠ°Π»ΡΠ²Π°ΠΌΠ΅, Π½ΠΎ Π½ΡΠΌΠ° ΡΠ΅Π²ΡΡΠ°, ΠΊΠΎΠΈΡΠΎ Π΄Π° ΠΎΡΠ³ΠΎΠ²Π°ΡΡΡ Π½Π° ΡΠ΅ΠΊΡΡΠΈΡΠ΅ Π²ΠΈ ΠΈΠ·Π±ΠΎΡΠΈ
Π₯ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈ ΠΊΡΠΏΡΠ²Π°ΡΠΈ | ΠΠ·ΡΠ»Π΅Π΄Π²Π°Π½Π΅ Π½Π° Ρ ΠΈΠΌΠΈΠΊΠ°Π»ΠΈ, ΠΊΡΠΏΡΠ²Π°Π½Π΅ Ρ ΡΠ²Π΅ΡΠ΅Π½ΠΎΡΡ (B2B)
Chemical Shoppers Π΅ Π½Π°Π΄Π΅ΠΆΠ΄Π½Π° ΠΈ ΠΏΡΠΎΡΠ΅ΡΠΈΠΎΠ½Π°Π»Π½Π° ΠΎΠ½Π»Π°ΠΉΠ½ ΠΏΠ»Π°ΡΡΠΎΡΠΌΠ°, Π² ΠΊΠΎΡΡΠΎΒ ΠΈΠ·ΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΠΈ, Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠΈΠΈ, Π°ΠΊΠ°Π΄Π΅ΠΌΠΈΡΠ½ΠΈ ΠΈΠ½ΡΡΠΈΡΡΡΠΈΠΈ ΠΈ ΠΏΡΠΎΠΌΠΈΡΠ»Π΅Π½ΠΈ ΠΏΡΠ΅Π΄ΠΏΡΠΈΡΡΠΈΡ.Β ΠΠ°ΠΊΡΠΏΡΠ²Π°Π½Π΅ Π½Π° Ρ ΠΈΠΌΠΈΠΊΠ°Π»ΠΈ Π·Π° Π½Π°ΡΡΠ½ΠΈ ΠΈΠ·ΡΠ»Π΅Π΄Π²Π°Π½ΠΈΡ ΠΈ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΠΈ ΡΠ΅Π°ΠΊΡΠΈΠ²ΠΈ Ρ ΡΠΎΠΊΡΡ Π²ΡΡΡ ΡΒ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ, ΡΡΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠ΅ ΠΈ ΠΏΡΠΎΠ·ΡΠ°ΡΠ½ΠΎΡΡ. Π‘ΡΡΠ΅ΡΠ°Π²Π°ΠΌΠ΅ ΡΠ΅Ρ Π½ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΎΠΏΠΈΡ ΡΡΡ ΡΠΈΠ³ΡΡΠ½Π°, ΠΌΠΎΠ΄Π΅ΡΠ½Π° ΡΡΠ΅Π΄Π° Π·Π° Π΅Π»Π΅ΠΊΡΡΠΎΠ½Π½Π° ΡΡΡΠ³ΠΎΠ²ΠΈΡ Π·Π° ΠΏΡΠΎΡΠ΅ΡΠΈΠΎΠ½Π°Π»Π½ΠΈ ΠΊΡΠΏΡΠ²Π°ΡΠΈ Π²Β ΠΠΈΠ΄Π΅ΡΠ»Π°Π½Π΄ΠΈΡ, ΠΠ‘ ΠΈ Π² ΠΌΠ΅ΠΆΠ΄ΡΠ½Π°ΡΠΎΠ΄Π΅Π½ ΠΏΠ»Π°Π½.
ΠΠ°Π΄Π΅ΠΆΠ΄Π½Π° ΠΏΠ»Π°ΡΡΠΎΡΠΌΠ° Π·Π° ΠΠΈΠ΄Π΅ΡΠ»Π°Π½Π΄ΠΈΡ ΠΈ ΠΠ‘
Chemical Shoppers Π΅ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ΅Π½ Π·Π° Π²ΠΈΡΠΎΠΊΠΈΡΠ΅ ΠΈΠ·ΠΈΡΠΊΠ²Π°Π½ΠΈΡ Π½Π° Π΅Π²ΡΠΎΠΏΠ΅ΠΉΡΠΊΠΈΡ ΠΏΠ°Π·Π°Ρ Π·Π° Π½Π°ΡΡΠ½ΠΈ ΠΈΠ·ΡΠ»Π΅Π΄Π²Π°Π½ΠΈΡ ΠΈ ΠΏΡΠΎΠΌΠΈΡΠ»Π΅Π½ΠΎΡΡ. ΠΠΈΠ΅ ΡΠ°Π±ΠΎΡΠΈΠΌ ΡΡΠ²ΠΌΠ΅ΡΡΠ½ΠΎ ΡΒ ΠΎΠ΄ΠΈΡΠΈΡΠ°Π½ΠΈ Π΄ΠΎΡΡΠ°Π²ΡΠΈΡΠΈΒ ΠΈ ΡΠ΅ ΡΡΡΠ΅ΠΌΠΈΠΌ ΠΊΡΠΌ ΠΏΠΎΡΡΠΎΡΠ½Π½ΠΎ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ Π½Π° ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΡΠ΅, ΡΡΠ½Π° ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡ Π·Π° ΠΏΡΠΎΠΈΠ·Ρ ΠΎΠ΄Π° ΠΈ ΠΏΡΠΎΡΠ΅ΡΠΈΠΎΠ½Π°Π»Π½Π° Π΄ΠΎΠΊΡΠΌΠ΅Π½ΡΠ°ΡΠΈΡ Π½Π° ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΡΠ΅.
ΠΠ°ΠΊΠ²ΠΎ Π΄Π° ΠΎΡΠ°ΠΊΠ²Π°ΡΠ΅:
Π―ΡΠ½ΠΈ ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ²ΠΈ ΡΠΏΠ΅ΡΠΈΡΠΈΠΊΠ°ΡΠΈΠΈΒ ΠΈ ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡ Π·Π° ΠΏΠ°ΡΡΠΈΠ΄Π°ΡΠ° (ΠΊΠΎΠ³Π°ΡΠΎ Π΅ ΠΏΡΠΈΠ»ΠΎΠΆΠΈΠΌΠΎ).
SDS/MSDSΒ (ΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΠΎΠ½Π΅Π½ Π»ΠΈΡΡ Π·Π° Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡ), Π°ΠΊΠΎ ΠΈΠΌΠ° ΡΠ°ΠΊΡΠ².
ΠΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»Π½ΠΎ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎ Π·Π°Β Π°Π½Π°Π»ΠΈΠ·, Π½Π°ΡΡΠ½ΠΎΠΈΠ·ΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠΊΠ° ΠΈ ΡΠ°Π·Π²ΠΎΠΉΠ½Π° Π΄Π΅ΠΉΠ½ΠΎΡΡ ΠΈ ΠΏΡΠΎΠΌΠΈΡΠ»Π΅Π½ΠΈ ΠΏΡΠΎΡΠ΅ΡΠΈ.
ΠΡΠΎΡΠ΅ΡΠΈΠΎΠ½Π°Π»Π½ΠΎ ΠΎΠ±ΡΠ»ΡΠΆΠ²Π°Π½Π΅ Π½Π° ΠΊΠΎΡΠΏΠΎΡΠ°ΡΠΈΠ²Π½ΠΈ ΠΈ ΠΈΠ½ΡΡΠΈΡΡΡΠΈΠΎΠ½Π°Π»Π½ΠΈ ΠΏΠΎΡΡΡΠΊΠΈ
ΠΠ±ΡΠΈΡΠ΅Π½ ΡΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·ΠΈΡΠ°Π½ ΠΊΠ°ΡΠ°Π»ΠΎΠ³
ΠΠ°ΡΠ°Π»ΠΎΠ³ΡΡ Π½ΠΈ Π½Π΅ΠΏΡΠ΅ΠΊΡΡΠ½Π°ΡΠΎ ΡΠ΅ ΡΠ°Π·ΡΠ°ΡΡΠ²Π° ΠΈ Π²ΠΊΠ»ΡΡΠ²Π°:
ΠΠ·ΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠΊΠΈ Ρ ΠΈΠΌΠΈΠΊΠ°Π»ΠΈ ΠΈΒ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΠΈ ΡΠ΅Π°ΠΊΡΠΈΠ²ΠΈ
Π‘ΠΏΠ΅ΡΠΈΠ°Π»ΠΈΠ·ΠΈΡΠ°Π½ΠΈ (ΠΏΠΎ-ΡΡΠ΄ΠΊΠΎ ΡΡΠ΅ΡΠ°Π½ΠΈ) Π²ΡΡΠ·ΠΊΠΈ
Π₯ΠΈΠΌΠΈΠΊΠ°Π»ΠΈ Π² Π½Π°ΡΠΈΠΏΠ½ΠΎ ΡΡΡΡΠΎΡΠ½ΠΈΠ΅Β Π·Π° ΡΠΈΡΠΎΠΊΠΎΠΌΠ°ΡΠ°Π±Π½ΠΈ ΠΏΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΡ
ΠΠ΅ΠΏΡΠ΅ΠΊΡΡΠ½Π°ΡΠΎ ΡΠ°Π·ΡΠΈΡΡΠ²Π°ΠΌΠ΅ Π³Π°ΠΌΠ°ΡΠ°, Π·Π° Π΄Π° ΠΎΡΠ³ΠΎΠ²ΠΎΡΠΈΠΌ Π½Π° Π½ΠΎΠ²ΠΈΡΠ΅ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠΊΠΈ ΠΈ ΠΏΠ°Π·Π°ΡΠ½ΠΎΡΠΎ ΡΡΡΡΠ΅Π½Π΅ Π² ΠΠΈΠ΄Π΅ΡΠ»Π°Π½Π΄ΠΈΡ ΠΈ ΠΠ‘.
ΠΡΠΎΠ·ΡΠ°ΡΠ½ΠΎ ΡΠ΅Π½ΠΎΠΎΠ±ΡΠ°Π·ΡΠ²Π°Π½Π΅ ΠΈ ΠΎΡΡΡΡΠΏΠΊΠΈ Π·Π° ΠΎΠ±Π΅ΠΌ
ΠΡΡΠΆΠΊΠΈ Π·Π° ΠΊΡΠΏΡΠ²Π°ΡΠΈ Π½Π° Ρ ΠΈΠΌΠΈΠΊΠ°Π»ΠΈΒ ΡΡΠ½ΠΈ ΠΈ ΠΏΡΠΎΠ·ΡΠ°ΡΠ½ΠΈ ΡΠ΅Π½ΠΈ.Β Π±Π΅Π· ΡΠΊΡΠΈΡΠΈ ΡΠ°Π·Ρ ΠΎΠ΄ΠΈ. ΠΠ° ΠΊΠΎΡΠΏΠΎΡΠ°ΡΠΈΠ²Π½ΠΈ ΠΊΠ»ΠΈΠ΅Π½ΡΠΈ ΠΈ ΠΈΠ½ΡΡΠΈΡΡΡΠΈΠΈ ΠΏΡΠ΅Π΄Π»Π°Π³Π°ΠΌΠ΅Β ΠΎΡΡΡΡΠΏΠΊΠΈ Π·Π° ΠΎΠ±Π΅ΠΌΒ ΠΈ (ΠΊΠΎΠ³Π°ΡΠΎ Π΅ ΡΠΌΠ΅ΡΡΠ½ΠΎ)Β ΠΏΠ΅ΡΡΠΎΠ½Π°Π»ΠΈΠ·ΠΈΡΠ°Π½ΠΈ ΡΠΈΡΠ°ΡΠΈ, ΠΊΠΎΠ΅ΡΠΎ Π²ΠΈ ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ²Π° Π΄Π° ΠΏΠ»Π°Π½ΠΈΡΠ°ΡΠ΅ ΠΏΠΎΡΡΡΠΊΠΈΡΠ΅ ΠΏΠΎ-Π΅ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎ, Π±Π΅Π· Π΄Π° ΠΏΡΠ°Π²ΠΈΡΠ΅ ΠΊΠΎΠΌΠΏΡΠΎΠΌΠΈΡ Ρ ΠΊΠ°ΡΠ΅ΡΡΠ²ΠΎΡΠΎ ΠΈΠ»ΠΈ Π½Π°Π΄Π΅ΠΆΠ΄Π½ΠΎΡΡΡΠ°.
ΠΡΡΠ·Π° Π΄ΠΎΡΡΠ°Π²ΠΊΠ° ΠΈ ΡΡΠ²ΠΌΠ΅ΡΡΠΈΠΌΠ° ΠΎΠΏΠ°ΠΊΠΎΠ²ΠΊΠ°
ΠΡΠΈΠ³ΡΡΡΠ²Π°ΠΌΠ΅ Π½Π°Π΄Π΅ΠΆΠ΄Π½Π° ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠ° Π½Π° ΠΏΠΎΡΡΡΠΊΠΈΡΠ΅ ΠΈ Π΄ΠΎΡΡΠ°Π²ΠΊΠ° Π² ΠΠΈΠ΄Π΅ΡΠ»Π°Π½Π΄ΠΈΡ ΠΈ ΠΠ‘. ΠΡΠΎΠ΄ΡΠΊΡΠΈΡΠ΅ ΡΠ° Π²Π½ΠΈΠΌΠ°ΡΠ΅Π»Π½ΠΎ ΠΎΠΏΠ°ΠΊΠΎΠ²Π°Π½ΠΈ Π²Β Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½Π°, Π΄ΠΈΡΠΊΡΠ΅ΡΠ½Π° ΠΈ ΡΡΠ²ΠΌΠ΅ΡΡΠΈΠΌΠ° ΠΎΠΏΠ°ΠΊΠΎΠ²ΠΊΠ°Β ΠΈ ΡΠ΅ ΠΈΠ·ΠΏΡΠ°ΡΠ°Ρ ΡΡΠ΅Π· ΠΎΠ΄ΠΎΠ±ΡΠ΅Π½ΠΈ Π»ΠΎΠ³ΠΈΡΡΠΈΡΠ½ΠΈ ΠΏΠ°ΡΡΠ½ΡΠΎΡΠΈ, ΠΊΠ°ΡΠΎ ΡΠ΅ Π³Π°ΡΠ°Π½ΡΠΈΡΠ°, ΡΠ΅ ΠΏΡΠ°ΡΠΊΠΈΡΠ΅ ΠΏΡΠΈΡΡΠΈΠ³Π°Ρ ΠΏΡΠΈ ΠΏΠΎΠ΄Ρ ΠΎΠ΄ΡΡΠΈ ΡΡΠ»ΠΎΠ²ΠΈΡ ΠΈ ΠΎΡΠ³ΠΎΠ²Π°ΡΡΡ Π½Π° ΠΏΡΠΈΠ»ΠΎΠΆΠΈΠΌΠΈΡΠ΅ ΠΈΠ·ΠΈΡΠΊΠ²Π°Π½ΠΈΡ Π·Π° ΡΡΠ°Π½ΡΠΏΠΎΡΡ ΠΈ Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡ.
Π‘ΠΈΠ³ΡΡΠ½Π° ΠΊΠ°ΡΠ° ΠΈ ΠΏΡΠΎΡΠ΅ΡΠΈΠΎΠ½Π°Π»Π΅Π½ ΠΎΠΏΠΈΡ Π·Π° ΠΏΠΎΡΡΡΠΊΠ°
Π£Π΅Π± ΠΌΠ°Π³Π°Π·ΠΈΠ½ΡΡ Π΅ ΡΡΠ·Π΄Π°Π΄Π΅Π½ Π·Π° ΠΏΡΠΎΡΠ΅ΡΠΈΠΎΠ½Π°Π»Π½Π° ΡΠΏΠΎΡΡΠ΅Π±Π°, ΡΡΡ ΡΠΈΠ³ΡΡΠ½Π° ΡΡΠ΅Π΄Π° Π·Π° ΠΏΠ»Π°ΡΠ°Π½Π΅ ΠΈ Π½Π°Π΄Π΅ΠΆΠ΄Π½ΠΈ Π²ΡΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π·Π° ΠΏΠ»Π°ΡΠ°Π½Π΅. Π’ΠΎΠ²Π° ΠΏΠΎΠ·Π²ΠΎΠ»ΡΠ²Π° Π½Π° Π±ΠΈΠ·Π½Π΅Ρ ΠΊΠ»ΠΈΠ΅Π½ΡΠΈΡΠ΅ Π΄Π°Β Π±ΡΡΠ·ΠΎ, ΡΡΠ½ΠΎ ΠΈ ΡΠ²Π΅ΡΠ΅Π½ΠΎΒ ΠΏΠΎΡΡΡΠ²Π°Π½Π΅.
ΠΠ°ΡΠΎ Π΄Π° ΠΈΠ·Π±Π΅ΡΠ΅ΡΠ΅ Chemical Shoppers?
Π₯ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡΠ΅ ΠΊΡΠΏΡΠ²Π°ΡΠΈ ΡΠ΅ ΠΎΡΠ»ΠΈΡΠ°Π²Π°Ρ Ρ:
ΠΡΠΎΡΠ΅ΡΠΈΠΎΠ½Π°Π»Π½Π° Π½Π°ΡΠΎΡΠ΅Π½ΠΎΡΡ (B2B)
ΠΠΎΠΊΡΠΌΠ΅Π½ΡΠ°ΡΠΈΡ ΠΈ ΠΏΡΠΎΠ·ΡΠ°ΡΠ½ΠΎΡΡ (SDS/MSDS, Π°ΠΊΠΎ ΠΈΠΌΠ° ΡΠ°ΠΊΠΈΠ²Π°)
ΠΠ°Π΄Π΅ΠΆΠ΄Π½Π° ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠ° ΠΈ Π΄ΠΎΡΡΠ°Π²ΠΊΠ°
ΠΠΊΡΠΏΠ΅ΡΡΠ½ΠΎ ΠΎΠ±ΡΠ»ΡΠΆΠ²Π°Π½Π΅ Π½Π° ΠΊΠ»ΠΈΠ΅Π½ΡΠΈ
ΠΠ»Π°ΡΡΠΎΡΠΌΠ°, ΡΡΠ·Π΄Π°Π΄Π΅Π½Π° Π·Π° ΠΏΡΠΎΡΠ΅ΡΠΈΠΎΠ½Π°Π»Π½ΠΈ ΠΏΠΎΡΡΡΠΊΠΈ
ΠΠ°ΠΆΠ½Π° Π±Π΅Π»Π΅ΠΆΠΊΠ° Π·Π° ΡΡΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠ΅
ΠΠ°ΡΠΈΡΠ΅ ΠΏΡΠΎΠ΄ΡΠΊΡΠΈ ΡΠ° ΠΏΡΠ΅Π΄Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈ ΠΈΠ·ΠΊΠ»ΡΡΠΈΡΠ΅Π»Π½ΠΎ Π·Π°Β Π»Π΅Π³ΠΈΡΠΈΠΌΠ½ΠΈ ΠΈΠ·ΡΠ»Π΅Π΄Π²Π°Π½ΠΈΡ, Π°Π½Π°Π»ΠΈΠ·ΠΈ, ΠΏΡΠ΅ΠΏΠΎΠ΄Π°Π²Π°Π½Π΅ ΠΈΠ»ΠΈ ΠΏΡΠΎΠΌΠΈΡΠ»Π΅Π½ΠΈ ΠΏΡΠΈΠ»ΠΎΠΆΠ΅Π½ΠΈΡ..Β ΠΠ΅Β ΠΏΡΠ΅Π΄Π½Π°Π·Π½Π°ΡΠ΅Π½ΠΈ Π·Π° ΠΊΠΎΠ½ΡΡΠΌΠ°ΡΠΈΡ ΠΎΡ Ρ ΠΎΡΠ° ΠΈΠ»ΠΈ ΠΆΠΈΠ²ΠΎΡΠ½ΠΈ ΠΈΠ»ΠΈ Π·Π° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠ°/ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ½Π°/ΠΊΠΎΠ·ΠΌΠ΅ΡΠΈΡΠ½Π° ΡΠΏΠΎΡΡΠ΅Π±Π°. ΠΡΠΏΡΠ²Π°ΡΡΡ Π΅ ΠΎΡΠ³ΠΎΠ²ΠΎΡΠ΅Π½ Π·Π° ΡΠΏΠ°Π·Π²Π°Π½Π΅ΡΠΎ Π½Π° ΠΌΠ΅ΡΡΠ½ΠΈΡΠ΅ Π·Π°ΠΊΠΎΠ½ΠΈ ΠΈ ΡΠ°Π·ΠΏΠΎΡΠ΅Π΄Π±ΠΈ.
Β
